Johnson And Johnson
-
{
- All
- News
- Videos
-
J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test
The fate of Johnson & Johnson's latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January.
-
Johnson And Johnson India Unveils Enhanced Paternity Leave
Johnson and Johnson India's paternal and maternal leave policies are at par with its global practice.
-
First Dengue Pill Shows Promising Results In Human Challenge Trial
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.
-
Court Rescinds Ban, Allows Johnson & Johnson To Make, Sell Baby Powder
The Bombay High Court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Johnson And Johnson Sees New Allegations In Baby Powder Case
A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
South Africa Pulls 2 Million Johnson & Johnson Covid Vaccine Doses
South Africa, which is struggling to roll out its inoculation programme as it enters a third wave of the coronavirus pandemic, said Sunday it will pull two million of doses Johnson & Johnson vaccine.
-
Centre Looking Into Securing Part Of J&J Vaccine Shots For India: Report
J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.
-
US Looking At Joint Production Of Johnson And Johnson's In India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
-
J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test
The fate of Johnson & Johnson's latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January.
-
Johnson And Johnson India Unveils Enhanced Paternity Leave
Johnson and Johnson India's paternal and maternal leave policies are at par with its global practice.
-
First Dengue Pill Shows Promising Results In Human Challenge Trial
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.
-
Court Rescinds Ban, Allows Johnson & Johnson To Make, Sell Baby Powder
The Bombay High Court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Johnson And Johnson Sees New Allegations In Baby Powder Case
A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
South Africa Pulls 2 Million Johnson & Johnson Covid Vaccine Doses
South Africa, which is struggling to roll out its inoculation programme as it enters a third wave of the coronavirus pandemic, said Sunday it will pull two million of doses Johnson & Johnson vaccine.
-
Centre Looking Into Securing Part Of J&J Vaccine Shots For India: Report
J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.
-
US Looking At Joint Production Of Johnson And Johnson's In India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
